Zobrazeno 1 - 10
of 498
pro vyhledávání: '"M. Strolin Benedetti"'
Autor:
P. Espie, Rhys Whomsley, Michael Canning, François-Xavier Mathy, M. Strolin Benedetti, P. Jacques
Publikováno v:
Fundamental & Clinical Pharmacology. 22:19-23
Competition for uptake and/or efflux transporters can be responsible for drug interactions. Cetirizine is mainly eliminated unchanged in urine through both glomerular filtration and tubular secretion. The aim of this study was to investigate whether
Autor:
Jean-Marie Nicolas, P Collart, Rhys Whomsley, René Coupez, Eugène Baltes, M. Strolin Benedetti
Publikováno v:
Xenobiotica. 34:281-300
1: The pharmacokinetics and metabolism of 14C-levetiracetam, a new anti-epileptic agent, in mouse, rat, rabbit and dog after a single oral dose were investigated. Moreover, the in vitro hydrolysis of levetiracetam to its major carboxylic metabolite b
Autor:
Eugène Baltes, M. Strolin Benedetti
Publikováno v:
Fundamental & Clinical Pharmacology. 17:281-299
Key factors undergoing maturational changes accounting for differences in drug metabolism and disposition in the pediatric population compared with adults are reviewed. Gastric and duodenal pH, gastric emptying time, intestinal transit time, bacteria
Publikováno v:
Journal of Controlled Release. 49:115-122
In the early stages of product development for novel colonic delivery systems, considerable time can be lost in establishing the likely potential of any given research strategy because of a lack of suitable in vitro or animal models. We therefore rep
Autor:
R. Spinelli, E. Frigerio, D. Sassella, M. Strolin Benedetti, Italo Poggesi, R. Rimoldi, L. Carrà
Publikováno v:
Journal of Antimicrobial Chemotherapy. 40:291-294
The pharmacokinetics of ritipenem acoxil, the oral prodrug of the antibiotic ritipenem, were studied in volunteers after single and repeated dosing (500 mg, three times daily for 10 days). Concentrations of ritipenem and open beta-lactam ring metabol
Autor:
C. Pellizzoni, Philippe Dostert, A. Benecchi, G. Brianceschi, Italo Poggesi, E. Frigerio, M. Strolin Benedetti
Publikováno v:
Chirality. 9:303-306
Reboxetine, (RS)-2-[(RS)-alpha-(2-ethoxyphenoxy)benzyl]morpholine methanesulphonate, is a racemic compound and consists of a mixture of the (R,R)- and (S,S)-enantiomers. The pharmacokinetics of reboxetine enantiomers were determined in a crossover st
Publikováno v:
Inflammation Research. 54:367-369
The predictive efficacy of drugs in humans is frequently estimated from both a high affinity for their receptor as measured in vitro and a long plasmatic half-life. This is grossly misleading since one key parameter is missing: drug concentration at
Publikováno v:
European Journal of Pharmaceutical Sciences. 4:331-340
A procedure for the determination of exemestane, a new aromatase inhibitor, in biological fluids is described in this paper. Exemestane is extracted from human plasma and urine by solid-phase and liquid-liquid extraction, respectively. The test compo
Autor:
C. Pellizzoni, Italo Poggesi, N. P. Jørgensen, D. M. F. Edwards, M. Strolin Benedetti, E. Paus
Publikováno v:
Biopharmaceutics & Drug Disposition. 17:623-633
The pharmacokinetics of reboxetine have been investigated in 12 healthy male volunteers after a single 2 mg dose of reboxetine and at steady state, following the last administration of a multiple-dose regimen (2mg twice a day for 5 1/2 d). Reboxetine
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 681:185-190
A new sensitive high-performance liquid chromatographic (HPLC) method with fluorescence detection was developed for the determination of 2-phenylethylamine (PEA) in human urine. The analytical procedure involved a simple extraction of the analyte fro